Tag: Presented
Lottery Registration for 2020 Empire State Building Run-Up Presented by Turkish Airlines Powered by the Challenged Athletes Foundation Opens on J

Lottery Registration for 2020 Empire State Building Run-Up Presented by Turkish Airlines Powered by the Challenged Athletes Foundation Opens on J

The 43rd Annual Event is Scheduled for Tuesday, May 12, 2020 NEW YORK, Dec. 18, 2019 /PRNewswire/ -- Empire State Realty Trust, Inc. today announced that lottery registration ...

Lees verder
New Data for BAVENCIO® (avelumab) for Advanced Cancers to Be Presented at ESMO 2019

New Data for BAVENCIO® (avelumab) for Advanced Cancers to Be Presented at ESMO 2019

Not intended for US, Canada and UK-based media DARMSTADT, Germany, and NEW YORK, Sept. 27, 2019 /PRNewswire/ -- Merck and Pfizer Inc. today announced the presentation of ...

Lees verder
Daiichi Sankyo Announces the Presentation of New Data on LIXIANA®▼ (edoxaban) to be Presented at ESC Congress 2019

Daiichi Sankyo Announces the Presentation of New Data on LIXIANA®▼ (edoxaban) to be Presented at ESC Congress 2019

- Data presentations from ENTRUST-AF PCI and ETNA-AF add to the growing body of scientific evidence from the Edoxaban Clinical Research Programme - First-time presentation of ...

Lees verder
Empire State Building Run-Up Presented by Turkish Airlines Powered by the Challenged Athletes Foundation

Empire State Building Run-Up Presented by Turkish Airlines Powered by the Challenged Athletes Foundation

9-Time Winner Suzy Walsham Returns To Defend Her Title NEW YORK, May 13, 2019 /PRNewswire/ -- Today, the Empire State Building announced that elite tower runner Suzy Walsham ...

Lees verder
LIXIANA® ▼ (edoxaban) Shows Reduced Rate of a Variety of Types of Intracranial Haemorrhage Compared to Warfarin in New Sub-analysis Presented at

LIXIANA® ▼ (edoxaban) Shows Reduced Rate of a Variety of Types of Intracranial Haemorrhage Compared to Warfarin in New Sub-analysis Presented at

MUNICH, May 18, 2018 /PRNewswire/ -- - Sub-analysis presented from ENGAGE AF-TIMI 48, the longest single comparative global trial of a non-vitamin K oral ...

Lees verder
Semaglutide Injection Phase 2 Data Presented at ENDO Demonstrated Significant Weight Loss in Adults With Obesity

Semaglutide Injection Phase 2 Data Presented at ENDO Demonstrated Significant Weight Loss in Adults With Obesity

CHICAGO, March 19, 2018 /PRNewswire/ -- Oral session #12 Adults with obesity treated with semaglutide 0.4 mg administered once-daily via subcutaneous injections lost up to ...

Lees verder
4C Medical's Novel Mitral Regurgitation Therapy to be Presented at TCT 2017 Shark Tank Innovation Competition

4C Medical's Novel Mitral Regurgitation Therapy to be Presented at TCT 2017 Shark Tank Innovation Competition

BROOKLYN PARK, Minnesota, Oct. 24, 2017 /PRNewswire/ -- 4C Medical Technologies, Inc. (4C Medical), a developer of minimally invasive technologies for structural heart disease, ...

Lees verder
New data Presented at ERS 2017 on flutiform® k-haler®(fluticasone propionate and formoterol), Mundipharma's Novel Breath-triggered Aerosol Inhale

New data Presented at ERS 2017 on flutiform® k-haler®(fluticasone propionate and formoterol), Mundipharma's Novel Breath-triggered Aerosol Inhale

CAMBRIDGE, England, September 10, 2017 /PRNewswire/ -- - flutiform k-haler achieved high levels of lung deposition of over 44% of delivered dose - ...

Lees verder
BizPress.nl